Evidence in palliative care research: How should it be gathered?

Medical Journal of Australia

Volumn 183, Issue 5, 2005, Pages 264-266

  Aoun, Samar M ^a   Kristjanson, Linda J ^a,b  

^a EDITH COWAN UNIVERSITY   (Australia)

^b Department of Palliative Care ^*  (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL STUDY; EVIDENCE BASED MEDICINE; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HEALTH SERVICE; INFORMATION PROCESSING; MEDICAL RESEARCH; MORBIDITY; OUTCOMES RESEARCH; PALLIATIVE THERAPY; PRACTICE GUIDELINE; QUALITATIVE ANALYSIS; QUALITY OF LIFE; REVIEW; SURVIVAL RATE; TAXONOMY;

EID: 24344487369     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2005.tb07034.x     Document Type: Review

References (26)

1. National Health and Medical Research Council. NHMRC standards and procedures for externally developed clinical practice guidelines. Canberra: NHMRC, 2005. Available at: http://www.nhmrc.gov.au/publications/pdf/nh56.pdf (accessed Jun 2005).
2. Sackett D, Rosenberg W, Gray J, et al. Evidence based medicine: what it is and what it isn't. BMJ 1996; 312: 71-72.
3. Haynes RB, Devereaux PJ, Guyatt GH. Physicians' and patients' choices in evidence based practice. BMJ 2002; 324: 1350.
4. Rychetnik L, Frommer M, Hawe P, Shiell A. Criteria for evaluating evidence on public health interventions. J Epidemiol Community Health 2002; 56: 119-127.
5. Williams D, Garner J. The case against "the evidence": a different perspective on evidence-based medicine. Br J Psychiatry 2002; 180: 8-12.
6. Concato J, Shah N, Horwitz N. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med 2000; 342: 1887-1892.
7. Ioannidis JP, Haidich AB, Lau J. Any casualties in the clash of randomised and observational evidence? BMJ 2001; 322: 879-880.
8. Deeks JJ, D'Amico R, Sakarovitch C, Altman DG. How big are the biases associated with non-randomised designs used in evaluations of healthcare interventions? An empirical investigation [abstract]. Oral presentation at the 3rd Symposium on Systematic Reviews: beyond the basics. Improving quality and impact; 2000 Jul 3-5; Oxford, UK. Available at: http://www.ihs.ox.ac.uk/csm/Oralabstract2K.htm#Deeks1 (accessed Jun 2005).
9. Bennett M, Ahmedzai M; APM Science Committee Association for Palliative Medicine. Evidence-based clinical guidelines for palliative care: the work of the APM Science Committee. Palliat Med 2000; 14: 453-454.
10. Hudson P, Aranda S, McMurray N. Randomized controlled trials in palliative care: overcoming the obstacles. Int J Palliat Nurs 2001; 7: 427-434.
11. King M. The effects of patients' and practitioners' preferences on randomized clinical trials. Palliat Med 2000; 14: 539-542.
12. Harding R, Higginson R. What is the best way to help caregivers in cancer and palliative care? A systematic literature review of interventions and their effectiveness. Palliat Med 2003; 17: 63-74.
13. Grande GE, Todd CJ. Why are trials in palliative care so difficult? Palliat Med 2000; 14: 69-74.
14. Aldrich R, Kemp L, Williams L, et al. Using socioeconomic evidence in clinical practice guidelines. BMJ 2003; 327: 1283-1285.
15. National Health and Medical Research Council. A guide to the development, implementation and evaluation of clinical practice guidelines. Canberra: NHMRC, 1999.
16. Keeley D. Rigorous assessment of palliative care revisited. Wisdom and compassion are needed when evidence is lacking. BMJ 1999; 319: 1447-1448.
17. Grande GE, Todd CJ, Barclay SI, Farquhar M. Does hospital at home for palliative care facilitate death at home? Randomised controlled trial. BMJ 1999; 319: 1472-1475.
18. Australian Government Department of Health and Ageing. Guidelines for a palliative approach in residential aged care. Canberra: The Department, 2004. Available at: http://www.health.gov.au/internet/wcms/publishing.nsf/Content/ palliativecare-pubs-workf-guide.htm/$FILE/guideall.pdf (accessed Jun 2005).
19. National Health and Medical Research Council. How to use the evidence: assessment and application of scientific evidence. Canberra: NHMRC, 2000.
20. Raphael D. The question of evidence in health promotion. Health Promot Int 2000; 15: 355-367.
21. Tammemagi C, Neslund-Dudas C, Simoff M, Kvale P. In lung cancer patients, age, race-ethnicity, gender and smoking predict adverse comorbidity, which in turn predicts treatment and survival. J Clin Epidemiol 2004; 57: 597-609.
22. Kemp L, Harris E, Aldrich R, et al. Randomised controlled trials and equity-based evidence. In: Ritchie J, editor. Made in the future. Proceedings of the 14th Annual Conference of the Australian Health Promotion Association; 2002 Jun 16-19; Sydney. Maroochydore, Qld: The Association.
23. Jackson K, Ashby M, Martin P, et al. "Burst" ketamine for refractory cancer pain: an open label audit of 39 patients. J Pain Symptom Manage 2001; 22: 834-842.
24. Jackson K, Ashby M, Goodchild C. Subanesthetic ketamine for cancer pain: by insisting on level I/II evidence, do we risk throwing the baby out with the bath water? J Pain Symptom Manage 2005; 29: 328-330.
25. Lynn J, Nolan K, Kabcenell A, et al. Reforming care for persons near the end of life: the promise of quality improvement. Ann Intern Med 2002; 137: 117-122.
26. Abernethy A, Currow D, Frith P, et al. Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea. BMJ 2003; 327: 523-528.